nodes	percent_of_prediction	percent_of_DWPC	metapath
Selegiline—CYP2A6—Ifosfamide—testicular cancer	0.118	0.165	CbGbCtD
Selegiline—CYP2B6—Ifosfamide—testicular cancer	0.0771	0.107	CbGbCtD
Selegiline—CYP2C8—Ifosfamide—testicular cancer	0.0584	0.0813	CbGbCtD
Selegiline—CYP2C19—Ifosfamide—testicular cancer	0.049	0.0682	CbGbCtD
Selegiline—CYP2C9—Ifosfamide—testicular cancer	0.0407	0.0567	CbGbCtD
Selegiline—CYP2B6—Cisplatin—testicular cancer	0.0375	0.0522	CbGbCtD
Selegiline—CYP2E1—Etoposide—testicular cancer	0.0373	0.052	CbGbCtD
Selegiline—ABCB1—Dactinomycin—testicular cancer	0.0335	0.0466	CbGbCtD
Selegiline—CYP2C8—Etoposide—testicular cancer	0.0279	0.0389	CbGbCtD
Selegiline—CYP2B6—Doxorubicin—testicular cancer	0.0251	0.035	CbGbCtD
Selegiline—CYP3A4—Ifosfamide—testicular cancer	0.0237	0.033	CbGbCtD
Selegiline—CYP1A2—Etoposide—testicular cancer	0.0216	0.0301	CbGbCtD
Selegiline—ABCB1—Vinblastine—testicular cancer	0.021	0.0292	CbGbCtD
Selegiline—CYP2C9—Cisplatin—testicular cancer	0.0198	0.0276	CbGbCtD
Selegiline—CYP2D6—Vinblastine—testicular cancer	0.0197	0.0275	CbGbCtD
Selegiline—ABCB1—Cisplatin—testicular cancer	0.0192	0.0268	CbGbCtD
Selegiline—ABCB1—Etoposide—testicular cancer	0.0189	0.0263	CbGbCtD
Selegiline—ABCB1—Doxorubicin—testicular cancer	0.0129	0.0179	CbGbCtD
Selegiline—CYP3A4—Vinblastine—testicular cancer	0.0126	0.0175	CbGbCtD
Selegiline—ABCB1—Methotrexate—testicular cancer	0.0125	0.0174	CbGbCtD
Selegiline—CYP2D6—Doxorubicin—testicular cancer	0.0121	0.0169	CbGbCtD
Selegiline—CYP3A4—Etoposide—testicular cancer	0.0113	0.0158	CbGbCtD
Selegiline—CYP3A4—Doxorubicin—testicular cancer	0.00772	0.0107	CbGbCtD
Selegiline—Vomiting—Ifosfamide—testicular cancer	0.000131	0.000464	CcSEcCtD
Selegiline—Hypersensitivity—Cisplatin—testicular cancer	0.000131	0.000463	CcSEcCtD
Selegiline—Bradycardia—Epirubicin—testicular cancer	0.00013	0.000462	CcSEcCtD
Selegiline—Rash—Ifosfamide—testicular cancer	0.00013	0.00046	CcSEcCtD
Selegiline—Dermatitis—Ifosfamide—testicular cancer	0.00013	0.000459	CcSEcCtD
Selegiline—Neuropathy peripheral—Doxorubicin—testicular cancer	0.00013	0.000459	CcSEcCtD
Selegiline—Urticaria—Etoposide—testicular cancer	0.000129	0.000457	CcSEcCtD
Selegiline—Stomatitis—Doxorubicin—testicular cancer	0.000129	0.000456	CcSEcCtD
Selegiline—Rhinitis—Epirubicin—testicular cancer	0.000129	0.000455	CcSEcCtD
Selegiline—Abdominal pain—Etoposide—testicular cancer	0.000128	0.000455	CcSEcCtD
Selegiline—Body temperature increased—Etoposide—testicular cancer	0.000128	0.000455	CcSEcCtD
Selegiline—Conjunctivitis—Doxorubicin—testicular cancer	0.000128	0.000455	CcSEcCtD
Selegiline—Urinary tract infection—Doxorubicin—testicular cancer	0.000128	0.000455	CcSEcCtD
Selegiline—Hepatitis—Epirubicin—testicular cancer	0.000128	0.000454	CcSEcCtD
Selegiline—Tinnitus—Methotrexate—testicular cancer	0.000128	0.000453	CcSEcCtD
Selegiline—Hypoaesthesia—Epirubicin—testicular cancer	0.000128	0.000452	CcSEcCtD
Selegiline—Asthenia—Cisplatin—testicular cancer	0.000127	0.000451	CcSEcCtD
Selegiline—Pharyngitis—Epirubicin—testicular cancer	0.000127	0.000451	CcSEcCtD
Selegiline—Sweating—Doxorubicin—testicular cancer	0.000127	0.000449	CcSEcCtD
Selegiline—Urinary tract disorder—Epirubicin—testicular cancer	0.000127	0.000449	CcSEcCtD
Selegiline—Oedema peripheral—Epirubicin—testicular cancer	0.000126	0.000448	CcSEcCtD
Selegiline—Haematuria—Doxorubicin—testicular cancer	0.000126	0.000446	CcSEcCtD
Selegiline—Urethral disorder—Epirubicin—testicular cancer	0.000126	0.000445	CcSEcCtD
Selegiline—Hepatobiliary disease—Doxorubicin—testicular cancer	0.000125	0.000443	CcSEcCtD
Selegiline—Epistaxis—Doxorubicin—testicular cancer	0.000125	0.000442	CcSEcCtD
Selegiline—Angiopathy—Methotrexate—testicular cancer	0.000124	0.00044	CcSEcCtD
Selegiline—Sinusitis—Doxorubicin—testicular cancer	0.000124	0.000439	CcSEcCtD
Selegiline—Visual impairment—Epirubicin—testicular cancer	0.000124	0.000438	CcSEcCtD
Selegiline—Chills—Methotrexate—testicular cancer	0.000123	0.000436	CcSEcCtD
Selegiline—Nausea—Ifosfamide—testicular cancer	0.000122	0.000433	CcSEcCtD
Selegiline—Diarrhoea—Cisplatin—testicular cancer	0.000121	0.00043	CcSEcCtD
Selegiline—Alopecia—Methotrexate—testicular cancer	0.000121	0.000429	CcSEcCtD
Selegiline—Bradycardia—Doxorubicin—testicular cancer	0.000121	0.000428	CcSEcCtD
Selegiline—Mental disorder—Methotrexate—testicular cancer	0.00012	0.000425	CcSEcCtD
Selegiline—Hypersensitivity—Etoposide—testicular cancer	0.00012	0.000424	CcSEcCtD
Selegiline—Tinnitus—Epirubicin—testicular cancer	0.00012	0.000424	CcSEcCtD
Selegiline—Malnutrition—Methotrexate—testicular cancer	0.000119	0.000423	CcSEcCtD
Selegiline—Erythema—Methotrexate—testicular cancer	0.000119	0.000423	CcSEcCtD
Selegiline—Flushing—Epirubicin—testicular cancer	0.000119	0.000422	CcSEcCtD
Selegiline—Rhinitis—Doxorubicin—testicular cancer	0.000119	0.000421	CcSEcCtD
Selegiline—Hepatitis—Doxorubicin—testicular cancer	0.000119	0.00042	CcSEcCtD
Selegiline—Hypoaesthesia—Doxorubicin—testicular cancer	0.000118	0.000418	CcSEcCtD
Selegiline—Pharyngitis—Doxorubicin—testicular cancer	0.000118	0.000417	CcSEcCtD
Selegiline—Urinary tract disorder—Doxorubicin—testicular cancer	0.000117	0.000415	CcSEcCtD
Selegiline—Oedema peripheral—Doxorubicin—testicular cancer	0.000117	0.000414	CcSEcCtD
Selegiline—Dysgeusia—Methotrexate—testicular cancer	0.000117	0.000414	CcSEcCtD
Selegiline—Asthenia—Etoposide—testicular cancer	0.000117	0.000413	CcSEcCtD
Selegiline—Angiopathy—Epirubicin—testicular cancer	0.000116	0.000412	CcSEcCtD
Selegiline—Urethral disorder—Doxorubicin—testicular cancer	0.000116	0.000412	CcSEcCtD
Selegiline—Back pain—Methotrexate—testicular cancer	0.000115	0.000409	CcSEcCtD
Selegiline—Chills—Epirubicin—testicular cancer	0.000115	0.000408	CcSEcCtD
Selegiline—Pruritus—Etoposide—testicular cancer	0.000115	0.000407	CcSEcCtD
Selegiline—Arrhythmia—Epirubicin—testicular cancer	0.000115	0.000406	CcSEcCtD
Selegiline—Visual impairment—Doxorubicin—testicular cancer	0.000114	0.000405	CcSEcCtD
Selegiline—Alopecia—Epirubicin—testicular cancer	0.000113	0.000401	CcSEcCtD
Selegiline—Vomiting—Cisplatin—testicular cancer	0.000113	0.0004	CcSEcCtD
Selegiline—Vision blurred—Methotrexate—testicular cancer	0.000112	0.000398	CcSEcCtD
Selegiline—Mental disorder—Epirubicin—testicular cancer	0.000112	0.000398	CcSEcCtD
Selegiline—Rash—Cisplatin—testicular cancer	0.000112	0.000396	CcSEcCtD
Selegiline—Dermatitis—Cisplatin—testicular cancer	0.000112	0.000396	CcSEcCtD
Selegiline—Erythema—Epirubicin—testicular cancer	0.000112	0.000395	CcSEcCtD
Selegiline—Malnutrition—Epirubicin—testicular cancer	0.000112	0.000395	CcSEcCtD
Selegiline—Diarrhoea—Etoposide—testicular cancer	0.000111	0.000394	CcSEcCtD
Selegiline—Ill-defined disorder—Methotrexate—testicular cancer	0.000111	0.000392	CcSEcCtD
Selegiline—Tinnitus—Doxorubicin—testicular cancer	0.000111	0.000392	CcSEcCtD
Selegiline—Anaemia—Methotrexate—testicular cancer	0.00011	0.000391	CcSEcCtD
Selegiline—Flushing—Doxorubicin—testicular cancer	0.00011	0.00039	CcSEcCtD
Selegiline—Flatulence—Epirubicin—testicular cancer	0.00011	0.00039	CcSEcCtD
Selegiline—Tension—Epirubicin—testicular cancer	0.000109	0.000388	CcSEcCtD
Selegiline—Dysgeusia—Epirubicin—testicular cancer	0.000109	0.000387	CcSEcCtD
Selegiline—Nervousness—Epirubicin—testicular cancer	0.000108	0.000384	CcSEcCtD
Selegiline—Back pain—Epirubicin—testicular cancer	0.000108	0.000383	CcSEcCtD
Selegiline—Angiopathy—Doxorubicin—testicular cancer	0.000108	0.000381	CcSEcCtD
Selegiline—Malaise—Methotrexate—testicular cancer	0.000108	0.000381	CcSEcCtD
Selegiline—Dizziness—Etoposide—testicular cancer	0.000107	0.000381	CcSEcCtD
Selegiline—Muscle spasms—Epirubicin—testicular cancer	0.000107	0.00038	CcSEcCtD
Selegiline—Vertigo—Methotrexate—testicular cancer	0.000107	0.00038	CcSEcCtD
Selegiline—Leukopenia—Methotrexate—testicular cancer	0.000107	0.000378	CcSEcCtD
Selegiline—Chills—Doxorubicin—testicular cancer	0.000106	0.000377	CcSEcCtD
Selegiline—Arrhythmia—Doxorubicin—testicular cancer	0.000106	0.000375	CcSEcCtD
Selegiline—Nausea—Cisplatin—testicular cancer	0.000105	0.000373	CcSEcCtD
Selegiline—Vision blurred—Epirubicin—testicular cancer	0.000105	0.000373	CcSEcCtD
Selegiline—Alopecia—Doxorubicin—testicular cancer	0.000105	0.000371	CcSEcCtD
Selegiline—Cough—Methotrexate—testicular cancer	0.000104	0.000369	CcSEcCtD
Selegiline—Mental disorder—Doxorubicin—testicular cancer	0.000104	0.000368	CcSEcCtD
Selegiline—Ill-defined disorder—Epirubicin—testicular cancer	0.000104	0.000367	CcSEcCtD
Selegiline—Convulsion—Methotrexate—testicular cancer	0.000103	0.000366	CcSEcCtD
Selegiline—Vomiting—Etoposide—testicular cancer	0.000103	0.000366	CcSEcCtD
Selegiline—Erythema—Doxorubicin—testicular cancer	0.000103	0.000366	CcSEcCtD
Selegiline—Malnutrition—Doxorubicin—testicular cancer	0.000103	0.000366	CcSEcCtD
Selegiline—Anaemia—Epirubicin—testicular cancer	0.000103	0.000366	CcSEcCtD
Selegiline—Agitation—Epirubicin—testicular cancer	0.000103	0.000363	CcSEcCtD
Selegiline—Rash—Etoposide—testicular cancer	0.000102	0.000363	CcSEcCtD
Selegiline—Dermatitis—Etoposide—testicular cancer	0.000102	0.000363	CcSEcCtD
Selegiline—Headache—Etoposide—testicular cancer	0.000102	0.000361	CcSEcCtD
Selegiline—Flatulence—Doxorubicin—testicular cancer	0.000102	0.000361	CcSEcCtD
Selegiline—Arthralgia—Methotrexate—testicular cancer	0.000102	0.00036	CcSEcCtD
Selegiline—Chest pain—Methotrexate—testicular cancer	0.000102	0.00036	CcSEcCtD
Selegiline—Myalgia—Methotrexate—testicular cancer	0.000102	0.00036	CcSEcCtD
Selegiline—Tension—Doxorubicin—testicular cancer	0.000101	0.000359	CcSEcCtD
Selegiline—Dysgeusia—Doxorubicin—testicular cancer	0.000101	0.000358	CcSEcCtD
Selegiline—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000101	0.000357	CcSEcCtD
Selegiline—Malaise—Epirubicin—testicular cancer	0.000101	0.000357	CcSEcCtD
Selegiline—Discomfort—Methotrexate—testicular cancer	0.0001	0.000355	CcSEcCtD
Selegiline—Nervousness—Doxorubicin—testicular cancer	0.0001	0.000355	CcSEcCtD
Selegiline—Vertigo—Epirubicin—testicular cancer	0.0001	0.000355	CcSEcCtD
Selegiline—Syncope—Epirubicin—testicular cancer	0.0001	0.000355	CcSEcCtD
Selegiline—Leukopenia—Epirubicin—testicular cancer	9.99e-05	0.000354	CcSEcCtD
Selegiline—Back pain—Doxorubicin—testicular cancer	9.99e-05	0.000354	CcSEcCtD
Selegiline—Muscle spasms—Doxorubicin—testicular cancer	9.93e-05	0.000352	CcSEcCtD
Selegiline—Palpitations—Epirubicin—testicular cancer	9.86e-05	0.000349	CcSEcCtD
Selegiline—Confusional state—Methotrexate—testicular cancer	9.81e-05	0.000348	CcSEcCtD
Selegiline—Loss of consciousness—Epirubicin—testicular cancer	9.81e-05	0.000348	CcSEcCtD
Selegiline—Cough—Epirubicin—testicular cancer	9.74e-05	0.000345	CcSEcCtD
Selegiline—Vision blurred—Doxorubicin—testicular cancer	9.73e-05	0.000345	CcSEcCtD
Selegiline—Convulsion—Epirubicin—testicular cancer	9.67e-05	0.000343	CcSEcCtD
Selegiline—Infection—Methotrexate—testicular cancer	9.67e-05	0.000343	CcSEcCtD
Selegiline—Nausea—Etoposide—testicular cancer	9.65e-05	0.000342	CcSEcCtD
Selegiline—Hypertension—Epirubicin—testicular cancer	9.63e-05	0.000341	CcSEcCtD
Selegiline—Ill-defined disorder—Doxorubicin—testicular cancer	9.58e-05	0.000339	CcSEcCtD
Selegiline—Nervous system disorder—Methotrexate—testicular cancer	9.54e-05	0.000338	CcSEcCtD
Selegiline—Anaemia—Doxorubicin—testicular cancer	9.54e-05	0.000338	CcSEcCtD
Selegiline—Thrombocytopenia—Methotrexate—testicular cancer	9.53e-05	0.000338	CcSEcCtD
Selegiline—Arthralgia—Epirubicin—testicular cancer	9.5e-05	0.000337	CcSEcCtD
Selegiline—Chest pain—Epirubicin—testicular cancer	9.5e-05	0.000337	CcSEcCtD
Selegiline—Myalgia—Epirubicin—testicular cancer	9.5e-05	0.000337	CcSEcCtD
Selegiline—Agitation—Doxorubicin—testicular cancer	9.49e-05	0.000336	CcSEcCtD
Selegiline—Anxiety—Epirubicin—testicular cancer	9.47e-05	0.000336	CcSEcCtD
Selegiline—Skin disorder—Methotrexate—testicular cancer	9.45e-05	0.000335	CcSEcCtD
Selegiline—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	9.43e-05	0.000334	CcSEcCtD
Selegiline—Hyperhidrosis—Methotrexate—testicular cancer	9.41e-05	0.000333	CcSEcCtD
Selegiline—Discomfort—Epirubicin—testicular cancer	9.39e-05	0.000333	CcSEcCtD
Selegiline—Malaise—Doxorubicin—testicular cancer	9.31e-05	0.00033	CcSEcCtD
Selegiline—Dry mouth—Epirubicin—testicular cancer	9.29e-05	0.000329	CcSEcCtD
Selegiline—Vertigo—Doxorubicin—testicular cancer	9.28e-05	0.000329	CcSEcCtD
Selegiline—Anorexia—Methotrexate—testicular cancer	9.28e-05	0.000329	CcSEcCtD
Selegiline—Syncope—Doxorubicin—testicular cancer	9.26e-05	0.000328	CcSEcCtD
Selegiline—Leukopenia—Doxorubicin—testicular cancer	9.24e-05	0.000328	CcSEcCtD
Selegiline—Confusional state—Epirubicin—testicular cancer	9.18e-05	0.000325	CcSEcCtD
Selegiline—Palpitations—Doxorubicin—testicular cancer	9.12e-05	0.000323	CcSEcCtD
Selegiline—Oedema—Epirubicin—testicular cancer	9.11e-05	0.000323	CcSEcCtD
Selegiline—Hypotension—Methotrexate—testicular cancer	9.09e-05	0.000322	CcSEcCtD
Selegiline—Loss of consciousness—Doxorubicin—testicular cancer	9.07e-05	0.000322	CcSEcCtD
Selegiline—Infection—Epirubicin—testicular cancer	9.05e-05	0.000321	CcSEcCtD
Selegiline—Cough—Doxorubicin—testicular cancer	9.01e-05	0.000319	CcSEcCtD
Selegiline—Shock—Epirubicin—testicular cancer	8.96e-05	0.000318	CcSEcCtD
Selegiline—Convulsion—Doxorubicin—testicular cancer	8.95e-05	0.000317	CcSEcCtD
Selegiline—Nervous system disorder—Epirubicin—testicular cancer	8.93e-05	0.000317	CcSEcCtD
Selegiline—Thrombocytopenia—Epirubicin—testicular cancer	8.92e-05	0.000316	CcSEcCtD
Selegiline—Hypertension—Doxorubicin—testicular cancer	8.91e-05	0.000316	CcSEcCtD
Selegiline—Tachycardia—Epirubicin—testicular cancer	8.89e-05	0.000315	CcSEcCtD
Selegiline—Musculoskeletal discomfort—Methotrexate—testicular cancer	8.87e-05	0.000314	CcSEcCtD
Selegiline—Skin disorder—Epirubicin—testicular cancer	8.85e-05	0.000313	CcSEcCtD
Selegiline—Hyperhidrosis—Epirubicin—testicular cancer	8.8e-05	0.000312	CcSEcCtD
Selegiline—Insomnia—Methotrexate—testicular cancer	8.8e-05	0.000312	CcSEcCtD
Selegiline—Chest pain—Doxorubicin—testicular cancer	8.79e-05	0.000312	CcSEcCtD
Selegiline—Arthralgia—Doxorubicin—testicular cancer	8.79e-05	0.000312	CcSEcCtD
Selegiline—Myalgia—Doxorubicin—testicular cancer	8.79e-05	0.000312	CcSEcCtD
Selegiline—Anxiety—Doxorubicin—testicular cancer	8.76e-05	0.00031	CcSEcCtD
Selegiline—Paraesthesia—Methotrexate—testicular cancer	8.74e-05	0.00031	CcSEcCtD
Selegiline—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	8.73e-05	0.000309	CcSEcCtD
Selegiline—Discomfort—Doxorubicin—testicular cancer	8.68e-05	0.000308	CcSEcCtD
Selegiline—Anorexia—Epirubicin—testicular cancer	8.68e-05	0.000308	CcSEcCtD
Selegiline—Dyspnoea—Methotrexate—testicular cancer	8.68e-05	0.000307	CcSEcCtD
Selegiline—Somnolence—Methotrexate—testicular cancer	8.65e-05	0.000307	CcSEcCtD
Selegiline—Dry mouth—Doxorubicin—testicular cancer	8.6e-05	0.000305	CcSEcCtD
Selegiline—Dyspepsia—Methotrexate—testicular cancer	8.57e-05	0.000304	CcSEcCtD
Selegiline—Hypotension—Epirubicin—testicular cancer	8.51e-05	0.000302	CcSEcCtD
Selegiline—Confusional state—Doxorubicin—testicular cancer	8.5e-05	0.000301	CcSEcCtD
Selegiline—Decreased appetite—Methotrexate—testicular cancer	8.46e-05	0.0003	CcSEcCtD
Selegiline—Oedema—Doxorubicin—testicular cancer	8.43e-05	0.000299	CcSEcCtD
Selegiline—Gastrointestinal disorder—Methotrexate—testicular cancer	8.4e-05	0.000298	CcSEcCtD
Selegiline—Fatigue—Methotrexate—testicular cancer	8.39e-05	0.000297	CcSEcCtD
Selegiline—Infection—Doxorubicin—testicular cancer	8.37e-05	0.000297	CcSEcCtD
Selegiline—Pain—Methotrexate—testicular cancer	8.32e-05	0.000295	CcSEcCtD
Selegiline—Musculoskeletal discomfort—Epirubicin—testicular cancer	8.3e-05	0.000294	CcSEcCtD
Selegiline—Shock—Doxorubicin—testicular cancer	8.29e-05	0.000294	CcSEcCtD
Selegiline—Nervous system disorder—Doxorubicin—testicular cancer	8.26e-05	0.000293	CcSEcCtD
Selegiline—Thrombocytopenia—Doxorubicin—testicular cancer	8.25e-05	0.000292	CcSEcCtD
Selegiline—Insomnia—Epirubicin—testicular cancer	8.24e-05	0.000292	CcSEcCtD
Selegiline—Tachycardia—Doxorubicin—testicular cancer	8.22e-05	0.000291	CcSEcCtD
Selegiline—Skin disorder—Doxorubicin—testicular cancer	8.18e-05	0.00029	CcSEcCtD
Selegiline—Paraesthesia—Epirubicin—testicular cancer	8.18e-05	0.00029	CcSEcCtD
Selegiline—Hyperhidrosis—Doxorubicin—testicular cancer	8.15e-05	0.000289	CcSEcCtD
Selegiline—Dyspnoea—Epirubicin—testicular cancer	8.12e-05	0.000288	CcSEcCtD
Selegiline—Somnolence—Epirubicin—testicular cancer	8.1e-05	0.000287	CcSEcCtD
Selegiline—Anorexia—Doxorubicin—testicular cancer	8.03e-05	0.000285	CcSEcCtD
Selegiline—Feeling abnormal—Methotrexate—testicular cancer	8.02e-05	0.000284	CcSEcCtD
Selegiline—Dyspepsia—Epirubicin—testicular cancer	8.02e-05	0.000284	CcSEcCtD
Selegiline—Gastrointestinal pain—Methotrexate—testicular cancer	7.96e-05	0.000282	CcSEcCtD
Selegiline—Decreased appetite—Epirubicin—testicular cancer	7.92e-05	0.000281	CcSEcCtD
Selegiline—Hypotension—Doxorubicin—testicular cancer	7.87e-05	0.000279	CcSEcCtD
Selegiline—Gastrointestinal disorder—Epirubicin—testicular cancer	7.86e-05	0.000279	CcSEcCtD
Selegiline—Fatigue—Epirubicin—testicular cancer	7.85e-05	0.000278	CcSEcCtD
Selegiline—Pain—Epirubicin—testicular cancer	7.79e-05	0.000276	CcSEcCtD
Selegiline—Constipation—Epirubicin—testicular cancer	7.79e-05	0.000276	CcSEcCtD
Selegiline—Urticaria—Methotrexate—testicular cancer	7.73e-05	0.000274	CcSEcCtD
Selegiline—Abdominal pain—Methotrexate—testicular cancer	7.69e-05	0.000273	CcSEcCtD
Selegiline—Body temperature increased—Methotrexate—testicular cancer	7.69e-05	0.000273	CcSEcCtD
Selegiline—Musculoskeletal discomfort—Doxorubicin—testicular cancer	7.68e-05	0.000272	CcSEcCtD
Selegiline—Insomnia—Doxorubicin—testicular cancer	7.62e-05	0.00027	CcSEcCtD
Selegiline—Paraesthesia—Doxorubicin—testicular cancer	7.57e-05	0.000268	CcSEcCtD
Selegiline—Dyspnoea—Doxorubicin—testicular cancer	7.51e-05	0.000266	CcSEcCtD
Selegiline—Feeling abnormal—Epirubicin—testicular cancer	7.5e-05	0.000266	CcSEcCtD
Selegiline—Somnolence—Doxorubicin—testicular cancer	7.49e-05	0.000265	CcSEcCtD
Selegiline—Gastrointestinal pain—Epirubicin—testicular cancer	7.45e-05	0.000264	CcSEcCtD
Selegiline—Dyspepsia—Doxorubicin—testicular cancer	7.42e-05	0.000263	CcSEcCtD
Selegiline—Decreased appetite—Doxorubicin—testicular cancer	7.33e-05	0.00026	CcSEcCtD
Selegiline—Gastrointestinal disorder—Doxorubicin—testicular cancer	7.27e-05	0.000258	CcSEcCtD
Selegiline—Fatigue—Doxorubicin—testicular cancer	7.26e-05	0.000257	CcSEcCtD
Selegiline—Urticaria—Epirubicin—testicular cancer	7.23e-05	0.000256	CcSEcCtD
Selegiline—Pain—Doxorubicin—testicular cancer	7.21e-05	0.000255	CcSEcCtD
Selegiline—Constipation—Doxorubicin—testicular cancer	7.21e-05	0.000255	CcSEcCtD
Selegiline—Body temperature increased—Epirubicin—testicular cancer	7.2e-05	0.000255	CcSEcCtD
Selegiline—Abdominal pain—Epirubicin—testicular cancer	7.2e-05	0.000255	CcSEcCtD
Selegiline—Hypersensitivity—Methotrexate—testicular cancer	7.17e-05	0.000254	CcSEcCtD
Selegiline—Asthenia—Methotrexate—testicular cancer	6.98e-05	0.000247	CcSEcCtD
Selegiline—Feeling abnormal—Doxorubicin—testicular cancer	6.94e-05	0.000246	CcSEcCtD
Selegiline—Gastrointestinal pain—Doxorubicin—testicular cancer	6.89e-05	0.000244	CcSEcCtD
Selegiline—Pruritus—Methotrexate—testicular cancer	6.88e-05	0.000244	CcSEcCtD
Selegiline—Hypersensitivity—Epirubicin—testicular cancer	6.71e-05	0.000238	CcSEcCtD
Selegiline—Urticaria—Doxorubicin—testicular cancer	6.69e-05	0.000237	CcSEcCtD
Selegiline—Abdominal pain—Doxorubicin—testicular cancer	6.66e-05	0.000236	CcSEcCtD
Selegiline—Body temperature increased—Doxorubicin—testicular cancer	6.66e-05	0.000236	CcSEcCtD
Selegiline—Diarrhoea—Methotrexate—testicular cancer	6.66e-05	0.000236	CcSEcCtD
Selegiline—Asthenia—Epirubicin—testicular cancer	6.53e-05	0.000232	CcSEcCtD
Selegiline—Pruritus—Epirubicin—testicular cancer	6.44e-05	0.000228	CcSEcCtD
Selegiline—Dizziness—Methotrexate—testicular cancer	6.44e-05	0.000228	CcSEcCtD
Selegiline—Diarrhoea—Epirubicin—testicular cancer	6.23e-05	0.000221	CcSEcCtD
Selegiline—Hypersensitivity—Doxorubicin—testicular cancer	6.21e-05	0.00022	CcSEcCtD
Selegiline—Vomiting—Methotrexate—testicular cancer	6.19e-05	0.000219	CcSEcCtD
Selegiline—Rash—Methotrexate—testicular cancer	6.14e-05	0.000217	CcSEcCtD
Selegiline—Dermatitis—Methotrexate—testicular cancer	6.13e-05	0.000217	CcSEcCtD
Selegiline—Headache—Methotrexate—testicular cancer	6.1e-05	0.000216	CcSEcCtD
Selegiline—Asthenia—Doxorubicin—testicular cancer	6.05e-05	0.000214	CcSEcCtD
Selegiline—Dizziness—Epirubicin—testicular cancer	6.02e-05	0.000213	CcSEcCtD
Selegiline—Pruritus—Doxorubicin—testicular cancer	5.96e-05	0.000211	CcSEcCtD
Selegiline—Vomiting—Epirubicin—testicular cancer	5.79e-05	0.000205	CcSEcCtD
Selegiline—Nausea—Methotrexate—testicular cancer	5.78e-05	0.000205	CcSEcCtD
Selegiline—Diarrhoea—Doxorubicin—testicular cancer	5.77e-05	0.000204	CcSEcCtD
Selegiline—Rash—Epirubicin—testicular cancer	5.74e-05	0.000203	CcSEcCtD
Selegiline—Dermatitis—Epirubicin—testicular cancer	5.74e-05	0.000203	CcSEcCtD
Selegiline—Headache—Epirubicin—testicular cancer	5.71e-05	0.000202	CcSEcCtD
Selegiline—Dizziness—Doxorubicin—testicular cancer	5.57e-05	0.000197	CcSEcCtD
Selegiline—Nausea—Epirubicin—testicular cancer	5.41e-05	0.000192	CcSEcCtD
Selegiline—Vomiting—Doxorubicin—testicular cancer	5.36e-05	0.00019	CcSEcCtD
Selegiline—Rash—Doxorubicin—testicular cancer	5.31e-05	0.000188	CcSEcCtD
Selegiline—Dermatitis—Doxorubicin—testicular cancer	5.31e-05	0.000188	CcSEcCtD
Selegiline—Headache—Doxorubicin—testicular cancer	5.28e-05	0.000187	CcSEcCtD
Selegiline—Nausea—Doxorubicin—testicular cancer	5.01e-05	0.000177	CcSEcCtD
